May 16, 2013
/PRNewswire/ -- Professional football icon
and Sanofi US, the makers of Auvi-Q™ (epinephrine injection, USP), have teamed up to raise awareness about severe allergic reactions (anaphylaxis) and introduce
The Severe Allergy & Anaphylaxis Playbook
– a collection of tips to help educate people living with severe allergies, and their friends and family, about avoiding allergens and being prepared in case of an emergency. Bettis, who is severely allergic to shellfish, is encouraging others impacted by severe allergies to download the
and use it in addition to the severe allergy treatment plan they develop with their healthcare provider.
To view the multimedia assets associated with this release, please click:
"On the football field it was essential for me to know my plays, and it's no different when it comes to my severe allergy. My game plan is to steer clear of my allergen and in case of accidental exposure, I always carry Auvi-Q, my epinephrine auto-injector, for the emergency treatment of life-threatening allergic reactions. Auvi-Q fits easily in my pocket and like a coach, talks me through the injection process," said Bettis. "Through my work with Sanofi US, I'm hoping to empower others living with severe allergies to equip themselves with smart defensive tactics."
Whether it's covering sugary drinks to avoid insect stings, asking a waiter about ingredients at a restaurant, or sharing an allergy ID card with a teacher – following a few simple steps may help reduce the risk of a severe allergic reaction.
Severe Allergy & Anaphylaxis Playbook
offers these tips and many others, including:
- The Bus' Blitz: Bettis' top five "plays" for defending against a severe allergic reaction
- Knowing Your Next Move: Strategies for avoiding major allergens, such as food, insect stings, latex and other triggers
- Away Game Plan: Advice for potentially challenging situations, such as dining out, picnicking, school and traveling
"Several studies indicate that the rate of anaphylaxis has increased in recent years, highlighting the need for continued education on allergen avoidance and the potential life-saving role of epinephrine," said Dr.
, a pediatric allergist, national expert in anaphylaxis and consultant to Sanofi US. "I always stress to my patients and their caregivers how important it is to implement appropriate measures for avoiding allergens and to carry an epinephrine auto-injector at all times."
Auvi-Q (epinephrine injection, USP) is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smartphone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process.